Raymond James Financial Services Advisors’s Blueprint Medicines BPMC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $3.48M | Buy |
|
|||||
|
2024
Q2 | $3.56M | Sell |
|
|||||
|
2024
Q1 | $3.5M | Buy |
|
|||||
|
2023
Q4 | $3.14M | Sell |
|
|||||
|
2023
Q3 | $2.14M | Sell |
|
|||||
|
2023
Q2 | $3.9M | Buy |
|
|||||
|
2023
Q1 | $1.59M | Sell |
|
|||||
|
2022
Q4 | $1.56M | Sell |
|
|||||
|
2022
Q3 | $2.91M | Buy |
|
|||||
|
2022
Q2 | $2.07M | Buy |
|
|||||
|
2022
Q1 | $2.13M | Sell |
|
|||||
|
2021
Q4 | $3.6M | Buy |
|
|||||
|
2021
Q3 | $2.85M | Buy |
|
|||||
|
2021
Q2 | $1.79M | Buy |
|
|||||
|
2021
Q1 | $1.93M | Sell |
|
|||||
|
2020
Q4 | $2.99M | Sell |
|
|||||
|
2020
Q3 | $3.21M | Sell |
|
|||||
|
2020
Q2 | $3M | Sell |
|
|||||
|
2020
Q1 | $2.34M | Buy |
|
|||||
|
2019
Q4 | $1.67M | Buy |
|
|||||
|
2019
Q3 | $204K | Sell |
|
|||||
|
2019
Q2 | $300K | Buy |
|
|||||
|
2017
Q3 | – | Sell |
|
|||||
|
2017
Q2 | $525K | Buy |
|